Reply: Familial ovarian screening: how to address abnormal TVU findings and its influence on the efficacy of screening?
until further notice
SourceBritish Journal of Cancer, 95, 8, (2006), pp. 1126-1127
Article / Letter to editor
Display more detailsDisplay less details
British Journal of Cancer
SubjectIGMD 3: Genomic disorders and inherited multi-system disorders; NCEBP 1: Molecular epidemiology; NCMLS 3: Growth and differentiation; NCMLS 6: Genetics and epigenetic pathways of disease; ONCOL 1: Hereditary cancer and cancer-related syndromes; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; UMCN 1.2: Molecular diagnosis, prognosis and monitoring; UMCN 1.4: Immunotherapy, gene therapy and transplantation; NCMLS 3: Growth and differentiation
Upload full text
Use your RU credentials (u/z-number and password) tolog in with SURFconextto upload a file for processing by the repository team.